August 24, 2021 | Blogs, Infographics
Drug Assessment Uncertainties: HTA Bodies vs. Regulators
A recent study of the review of new medicines by regulatory and HTA bodies has revealed areas of misalignment in their processes, highlighting unique challenges in the pathway to patient access.